RCS - Kromek Group PLC - Launch of new interactive investor hub

KromekAnnouncement

02/06/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260602:nRSB5479Ga&default-theme=true

RNS Number : 5479G  Kromek Group PLC  02 June 2026

2 June 2026

 

Kromek Group plc
("Kromek", the "Company" or the "Group")

 

Kromek launches new interactive investor hub

to provide shareholders with a more proactive way of communication and enquiry
support

 

Kromek (AIM:KMK), a global detection company focused on the advanced imaging
and CBRN detection markets, announces the launch of the Group's interactive
investor hub. For both existing and prospective shareholders, the new investor
hub brings all Kromek content into a single integrated platform to better
inform and engage with investors and other stakeholders, including:

 

●    Regulatory announcements

●    Reports

●    Presentations

●    Educational material

●    Interviews

●    Link to corporate research

●    All other disclosures required in accordance with AIM Rule 26

 

The investor hub also provides an interactive online experience allowing
Kromek stakeholders to comment on, and ask, the Kromek team questions via a
portal that will be monitored and responded to in a timely manner.

 

How to sign up for the Kromek Group plc investor hub:

1.   Visit https://investors.kromek.com/ (https://investors.kromek.com/)

2.   Follow the prompts to sign up for an investor hub account

3.   Complete your account profile

 

 

Enquiries

 

 Kromek Group plc                                                  We encourage all investors to share questions on this announcement via our
 Dr Arnab Basu, CEO                                                investor hub (https://investors.kromek.com/link/rvnWgr)

 Claire Burgess, CFO
 Cavendish Capital Markets Limited (Nominated Adviser and Broker)  +44 (0)20 7220 0500

 Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance

 Andrew Burdis - ECM

 Michael Johnson - Sales

 Gracechurch Group (Financial PR)                                  +44 (0)20 4582 3500

 Harry Chathli/Claire Norbury

 

Engage with the Kromek management team directly by asking questions, watching
video
summaries and seeing what other shareholders have to say. Navigate to
our interactive investor
hub here: https://investors.kromek.com/
(https://investors.kromek.com/)

 

Subscribe to our news alert service: https://investors.kromek.com/auth/signup
(https://investors.kromek.com/auth/signup)

 

Kromek Group plc

 

Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.

 

The advanced imaging segment comprises the medical (including CT and SPECT),
security and industrial markets. Kromek provides its OEM customers with
detector components, based on its core cadmium zinc telluride (CZT) platform,
to enable better detection of diseases such as cancer and Alzheimer's,
contamination in industrial manufacture and explosives in aviation settings.

 

In CBRN detection, the Group provides nuclear radiation detection solutions to
the global homeland defence and security market. Kromek's compact, handheld,
high-performance radiation detectors, based on advanced scintillation and
solid-state readout technology, are primarily used to protect critical
infrastructure, events, personnel and urban environments from the threat of
'dirty bombs'.

 

The Group is also developing bio-security solutions in the CBRN detection
segment. These consist of fully automated and autonomous systems to detect a
wide range of airborne pathogens.

 

Kromek is listed on AIM, a market of the London Stock Exchange, under the
trading symbol 'KMK'.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFLFEARTILIIR



            Copyright 2019 Regulatory News Service, all rights reserved